Adaptin Bio, Inc. Increase (Decrease) in Accrued Liabilities
Adaptin Bio, Inc. (APTN) reported Increase (Decrease) in Accrued Liabilities of $214.12 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-28
- Adaptin Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$42.78K.
- Adaptin Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $256.90K.
- Adaptin Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was -$260.03K.
- Adaptin Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was -$268.23K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|
| 2026-06-30 | -$42.78K derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | $214.12K S-1 · filed 2026-08-28 | |
| 2026-03-31 | $256.90K POS AM · filed 2026-07-21 | ||
| 2025-12-31 | -$453.44K S-1 · filed 2026-08-28 | ||
| 2025-06-30 | -$260.03K derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | -$528.25K S-1 · filed 2026-08-28 | |
| 2025-03-31 | -$268.23K POS AM · filed 2026-07-21 | ||
| 2024-12-31 | $851.31K S-1 · filed 2026-08-28 |